Angiotensin‐converting enzyme inhibitors increase anti‐fibrotic biomarkers in African Americans with left ventricular hypertrophy

Angiotensin‐converting enzyme inhibitors increase anti‐fibrotic biomarkers in African Americans with left ventricular hypertrophy

Abstract Angiotensin‐converting enzyme inhibitors (ACEi) are part of the indicated treatment in hypertensive African Americans. ACEi have blood pressure‐independent effects that may make them preferred for certain patients. We aimed to evaluate the impact of ACEi on anti‐fibrotic biomarkers in Afric...

Full description

Bibliographic Details
Main Authors: Cesar A.Romero, Shobi Mathew, Benjamin Wasinski, Brian Reed, Aaron Brody, Rachelle Dawood, Michael J. Twiner, Candace D. McNaughton, Rafael Fridman, John M. Flack, Oscar A. Carretero, Phillip D. Levy
Format: Article
Language:English
Published: Wiley 2021-05-01
Series:The Journal of Clinical Hypertension
Subjects:
ACE inhibitors
Ac‐SDKP
African American
collagen
left ventricular hypertrophy
MMP‐1
Online Access:https://doi.org/10.1111/jch.14206

Internet

https://doi.org/10.1111/jch.14206

Similar Items